Literature DB >> 7544761

Reactive pulmonary lymphoid disorders.

A G Nicholson1, A C Wotherspoon, T C Diss, D M Hansell, R Du Bois, M N Sheppard, P G Isaacson, B Corrin.   

Abstract

The two main reactive pulmonary lymphoid disorders are lymphoid interstitial pneumonia and follicular bronchitis/bronchiolitis, both pathological entities with a variety of aetiologies. We reviewed the morphological and immunohistochemical features of 26 cases with one or other of these two diagnoses, to explore the possibility that they represented overlapping patterns of hyperplasia of the bronchopulmonary immune system. The polymerase chain reaction was used to determine the clonality of the infiltrates. Histologically, there was a spectrum of changes with two main components. An interstitial infiltrate of mainly T lymphocytes, plasma cells and histiocytes predominated in lymphoid interstitial pneumonia, whilst lymphoid follicles predominated around airways in follicular bronchitis/bronchiolitis. Classification of the disorder rested on which component the pathologists believed to be dominant. In two cases, histology and immunohistochemistry suggested lymphoma, and in one of these cases this diagnosis was confirmed by the polymerase chain reaction. One case of lymphoid interstitial pneumonia produced three bands. The remainder produced polyclonal patterns when samples were adequate. Clinically, there was no clear difference between patients with the two disorders, or patients with pathological features of both.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7544761     DOI: 10.1111/j.1365-2559.1995.tb00247.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  20 in total

Review 1.  Non-neoplastic pulmonary lymphoid lesions.

Authors:  W D Travis; J R Galvin
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

Review 2.  The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Introduction.

Authors: 
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

Review 3.  Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches.

Authors:  Moisés Selman; Victor J Thannickal; Annie Pardo; David A Zisman; Fernando J Martinez; Joseph P Lynch
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 4.  Lymphocytic interstitial pneumonitis (LIP) in Sjögren's syndrome: a case report and a review of the literature.

Authors:  Vrishali Dalvi; Emilio B Gonzalez; Louis Lovett
Journal:  Clin Rheumatol       Date:  2006-08-05       Impact factor: 2.980

Review 5.  Diffuse Cystic Lung Disease. Part II.

Authors:  Nishant Gupta; Robert Vassallo; Kathryn A Wikenheiser-Brokamp; Francis X McCormack
Journal:  Am J Respir Crit Care Med       Date:  2015-07-01       Impact factor: 21.405

6.  A Case of Pulmonary MALT Lymphoma Arising from Lymphocytic Interstitial Pneumonitis.

Authors:  Ki Hoon Park; Soon Seog Kwon; Myung Hee Chung; Jeana Kim; Hee Jung Lee; Ji-Won Min; Yong Hyun Kim
Journal:  Tuberc Respir Dis (Seoul)       Date:  2012-08-31

7.  Granulomatous and lymphocytic interstitial lung disease: a spectrum of pulmonary histopathologic lesions in common variable immunodeficiency--histologic and immunohistochemical analyses of 16 cases.

Authors:  Nagarjun Rao; A Craig Mackinnon; John M Routes
Journal:  Hum Pathol       Date:  2015-06-01       Impact factor: 3.466

8.  Follicular bronchiolitis: a rare disease in children.

Authors:  Esra Toprak Kanık; Özge Yılmaz; Ahmet Türkeli; Şebnem Şahin; Hasan Yüksel
Journal:  Turk Pediatri Ars       Date:  2014-12-01

9.  Primary pulmonary T-cell lymphoma mimicking pneumonia: A case report and literature review.

Authors:  Lingyi Yang; Wei Feng; Cheng Chen; Xiuqin Zhang; Yehan Zhu; Wei Lei; Jian-An Huang
Journal:  Exp Ther Med       Date:  2016-04-21       Impact factor: 2.447

10.  Lung inflammation, injury, and proliferative response after repetitive particulate hexavalent chromium exposure.

Authors:  Laura M Beaver; Erik J Stemmy; Arnold M Schwartz; Jesse M Damsker; Stephanie L Constant; Susan M Ceryak; Steven R Patierno
Journal:  Environ Health Perspect       Date:  2009-08-19       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.